150 related articles for article (PubMed ID: 32716031)
21. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
22. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
23. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
[TBL] [Abstract][Full Text] [Related]
24. Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women.
Stracquadanio M; Ciotta L; Palumbo MA
Gynecol Endocrinol; 2018 Mar; 34(3):223-228. PubMed ID: 28944702
[TBL] [Abstract][Full Text] [Related]
25. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
26. Mesenchymal stem cell-derived apoptotic vesicles ameliorate impaired ovarian folliculogenesis in polycystic ovary syndrome and ovarian aging by targeting WNT signaling.
Fu Y; Zhang M; Sui B; Yuan F; Zhang W; Weng Y; Xiang L; Li C; Shao L; You Y; Mao X; Zeng H; Chen D; Zhang M; Shi S; Hu X
Theranostics; 2024; 14(8):3385-3403. PubMed ID: 38855175
[No Abstract] [Full Text] [Related]
27. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
[TBL] [Abstract][Full Text] [Related]
28. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
[TBL] [Abstract][Full Text] [Related]
29. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
30. Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries.
Stubbs SA; Hardy K; Da Silva-Buttkus P; Stark J; Webber LJ; Flanagan AM; Themmen AP; Visser JA; Groome NP; Franks S
J Clin Endocrinol Metab; 2005 Oct; 90(10):5536-43. PubMed ID: 16030171
[TBL] [Abstract][Full Text] [Related]
31. Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review.
Dumont A; Robin G; Catteau-Jonard S; Dewailly D
Reprod Biol Endocrinol; 2015 Dec; 13():137. PubMed ID: 26691645
[TBL] [Abstract][Full Text] [Related]
32. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
[TBL] [Abstract][Full Text] [Related]
33. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
[TBL] [Abstract][Full Text] [Related]
34. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
[TBL] [Abstract][Full Text] [Related]
35. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
Li Y; Wei LN; Xiong YL; Liang XY
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
[TBL] [Abstract][Full Text] [Related]
36. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
37. Anti-Müllerian hormone and polycystic ovary syndrome.
Bhide P; Homburg R
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234
[TBL] [Abstract][Full Text] [Related]
38. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
39. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
Chen MJ; Yang WS; Chen CL; Wu MY; Yang YS; Ho HN
Hum Reprod; 2008 Apr; 23(4):952-7. PubMed ID: 18256110
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
